Expression, Purification of IL-38 in Escherichia Coli and Production of Polyclonal Antibodies.
Zhonglan Hu,Zhenyu Chen,Nongyu Huang,Xiu Teng,Jun Zhang,Zhen Wang,Xiaoqiong Wei,Ke Qin,Xiao Liu,Xueping Wu,Huan Tang,Xiaofeng Zhu,Kaijun Cui,Jiong Li
DOI: https://doi.org/10.1016/j.pep.2014.10.016
IF: 2.025
2014-01-01
Protein Expression and Purification
Abstract:Members of the interleukin-1 (IL-1) family play important roles in inflammation and host defense against pathogens. Here, we describe a novel member of the IL-1 family, interleukin-38 (IL-38, IL-1F10, or IL-1HY2), which was discovered in 2001. Although the functional role of IL-38 remains unclear, recent reports show that IL-38 binds to the IL-36 receptor (IL-36R) which is also targeted by the IL-36 receptor antagonist (IL-36Ra). Consequently, these two molecules have similar effects on immune cells. Here, we describe the expression of soluble and active recombinant IL-38 in Escherichia coli (E. coli). The IL-38 gene sequence was optimized for expression in E. coli and then cloned into a pEHISTEV expression vector, which has an N-terminal 6-His affinity tag under control of the T7 lac strong promoter. Optimization of culture conditions allowed induction of the recombinant fusion protein with 0.1 mM isopropyl beta-D-1-thio galactoside (IPTG) at 37 degrees C for 4 h. The recombinant fusion protein was purified using an Ni affinity column and was further digested with TEV protease; the cleaved protein was purified by molecular-exclusion chromatography. Next, we measured IL-38 binding ability using functional ELISA. The purified proteins were used to immunize a New Zealand white rabbit four times to enable the production of polyclonal antibodies. The specificity of the prepared polyclonal antibodies was determined using Western blot, and the results showed they have high specificity against IL-38. Here, we describe the development of an effective and reliable method to express and purify IL-38 and anti-IL-38 antibodies. This will enable the function and structure of IL-38 to be determined. (C) 2014 Elsevier Inc. All rights reserved.